{
  "id": "R47653",
  "type": "CRS Report",
  "typeId": "R",
  "number": "R47653",
  "active": true,
  "source": "CRSReports.Congress.gov",
  "versions": [
    {
      "source_dir": "crsreports.congress.gov",
      "title": "The Orphan Drug Act and Catalyst Pharmaceuticals, Inc., v. Becerra",
      "retrieved": "2023-09-19T04:03:43.153364",
      "id": "R47653_1_2023-08-17",
      "formats": [
        {
          "filename": "files/2023-08-17_R47653_45e16bf1ce4289c3d4e131b84e4e44626070168d.pdf",
          "format": "PDF",
          "url": "https://crsreports.congress.gov/product/pdf/R/R47653/1",
          "sha1": "45e16bf1ce4289c3d4e131b84e4e44626070168d"
        },
        {
          "format": "HTML",
          "filename": "files/2023-08-17_R47653_45e16bf1ce4289c3d4e131b84e4e44626070168d.html"
        }
      ],
      "date": "2023-08-17",
      "summary": null,
      "source": "CRSReports.Congress.gov",
      "typeId": "R",
      "active": true,
      "sourceLink": "https://crsreports.congress.gov/product/details?prodcode=R47653",
      "type": "CRS Report"
    }
  ],
  "topics": []
}